population of the working age group and the increasing elderly population are matters of concern for US policy planners. The pharmaceutical market in US was estimated at approximately $ 359 billion in 2012 and is expected to reach approximately $ 475 billion by 2020, with a projected CAGR of 3.5 %. The medical device market size was approximately $ 138.9 billion in 2012 and is expected to reach approximately $ 206 billion by 2020, at a projected CAGR of 5.1 %.
Make an Enquiry: http:// www. marketresearchhub. com / enquiry. php? type = enquiry & re pid = 168755
Scope
� The report provides information on the healthcare, regulatory and reimbursement landscape of US. The scope of the report includes
� An overview of the pharmaceutical and medical devices market of US including the market size, market segmentation, key drivers and barriers for the market.
� Profiles and SWOT analyses of the major players in the pharmaceutical and medical devices market. Key players covered in the pharmaceutical market are Pfizer, Merck & Co., Roche, Abbott and Novartis. Key players covered for the medical devices market are Medtronic, Boston Scientific, Abbott, GlaxoSmithKline and Siemens Healthcare.
� An insightful review on the reimbursement and regulatory landscape. Analysis includes details of the healthcare reimbursement process, regulatory agencies and market authorization processes for new drug and medical devices for US.
� A detailed analysis of the political and economic environment of US, including economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
� An overview of the opportunities and challenges for growth that exist in the healthcare market of US.